Info

Gel Med Sciences (Gel Med) is a privately owned, specialty pharmaceutical company supported by angel and venture capital. The Company is developing animal and human healthcare products utilizing its proprietary Gel Drug Delivery System (GDDS). The GDDS is a novel transmucosal drug delivery method for systemic and/or local delivery of drugs that heretofore could only be delivered by injection. Gel Med's lead animal reproduction product is being funded by and co-developed with a corporate partner in the Animal Science Industry. Gel Med's plans to file its first Investigational New Drug Application (IND) in 2006 for its lead human healthcare product to treat infertility. Gel Med operates as a "virtual" company with management focused on advancing its technology and products using external service providers and academic and corporate partners for all development studies, allowing for a cost-effective, rapid and flexible development process. Gel Med is seeking additional co-development partnerships to develop a broader range of products that can benefit from the GDDS.